Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05364606

Patient Specific Talus Spacer Post Approval Study

Humanitarian Device Exemption Approved Patient Specific Talus Spacer Post Approval Study.

Recruiting

Interested in participating?

Request Info

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Redwood Orthopaedics, Santa Rosa, California, United States

Loading trial locations.

About this study

This is a Humanitarian Device Exemption (HDE) approved device called the Patient Specific Talus Spacer. This is a post approval study to determine the safety and probable benefit of the Patient Specific Talus Spacer in commercial use. The Patient Specific Talus Spacer is a solid polished replica of the patient's bone to allow the patient to regain motion and reduce pain.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject plans to undergo implantation of the Patient Specific Talus Spacer for avascular necrosis of the ankle joint independent of this research protocol;
  • Avascular necrosis of the ankle joint;
  • Age 21 years old or older;
  • Subject has good general health; and
  • Subject signs a written informed consent form (ICF) prior to the surgical procedure.

Exclusion criteria

  • Presence of any contraindication identified in the device Instructions for Use;
  • Surgeon determines that the patient is not appropriate for the Talus Spacer procedure based on the device IFU (including the enumerated Warnings and Precautions);
  • Based on the medical opinion of the surgeon, the patient is not appropriate for the Talus Spacer procedure;
  • For female subjects, pregnancy;
  • Active systemic disease, such as AIDS, HIV, or active infection;
  • Active infection or the skin is compromised at the surgical site; and
  • Systemic disease that would affect the subject's welfare;
  • Is a prisoner, incarcerated, or has been coerced to participate in the study that could impact the validity of results;
  • Is currently participating in an investigational therapy (device and/or pharmaceutical) within 30 days prior to entering the study or such treatment is planned during the time course of follow-up.
  • If the Sponsor has notified the site that 30 subjects have been enrolled in the study with a Cobalt Chromium Patient Specific Talus Spacer, and the surgeon believes that a Cobalt Chromium Patient Specific Talus Spacer is the best option for the patient.
  • If the Sponsor has notified the site that 30 subjects have been enrolled in the study with a Titanium (Ti6Al4V) with Titanium Nitride (TiN) coating Patient Specific Talus Spacer, and the surgeon believes that a Titanium (Ti6Al4V) with Titanium Nitride (TiN) coating Patient Specific Talus Spacer is the best option for the patient.

Treatment and study plan

Patient Specific Talus Spacer

Device

Patient Specific Talus Spacer is a solid polished replica of the patient's bone.

Primary outcomes

  1. Clinically Significant Improvement in Pain on the Visual Analog Scale (VAS)

    Time frame: At 5 years compared to Baseline

    Clinically Significant Improvement in Pain on the Visual Analog Scale (VAS) at 5 years compared to baseline on the 0 to 100mm scale. A lower score will indicate an improvement in pain.

  2. A lack Secondary Subsequent Surgical Intervention at 5 years Post Operative assessed during the subject's visits

    Time frame: A patient will achieve the primary probable benefit endpoint only is they do not undergo a Secondary Subsequent Surgical Intervention at 5 years Post Operative as assessed during the subjects visits for the study.

    A lack Secondary Subsequent Surgical Intervention (SSSI) at 5 years Post Operative

Secondary outcomes

  1. Additional Analyses at 5 years Post Operative compared to baseline, Range of Motion of the Ankle.

    Time frame: 5 Years Post Procedure compared to baseline.

    Additional analyses will be performed to observe improvement at 5-years post-procedure compared to baseline on ankle range of motion (ROM) as assessed by the surgeon at each follow up visit through 5 years Post Operative.

Other outcomes

  1. Additional Analyses at 5 Years Post Operative compared to Baseline for Foot and Outcome Score FAOS

    Time frame: 5 Years Post Procedure compared to baseline

    Additional analyses will be performed to observe improvement at 5-years post-procedure compared to baseline on Foot and Ankle Outcome Score (FAOS - which include Pain, Other Symptoms, Sport and Recreation Function, Activities of Daily Living (ADL) and Foot and Ankle related Quality of Life (QOL). This is a series of questions for each sub section that the subject will answer at the subjects visits.

Study contacts

Contact information is provided by the study sponsor or research team.

Caleigh Bates

CONTACT

[email protected]

720-399-3400

Jacy Legue

CONTACT

[email protected]

720-399-3400

Sponsors and collaborators

Lead sponsor

Paragon 28

Industry

Registry information

Important dates

Study start
2022
Primary completion
2029
Study completion
2029
First posted
May 6, 2022
Registry last updated
Nov 7, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.